S tudies from many different laboratories have
demonstrated the existence of high-affinity binding sites on cultured cells and cellular membranes that specifically bind high density lipoprotein (HDL). Recent studies from our laboratory have characterized a 110-kd membrane-binding protein that has many features in common with the high-affinity binding sites on intact cells. 1 The cellular binding sites and the isolated protein interact with HDL3 and phospholipid vesicles containing either apoprotein (apo) A-I or apo A-II 1 -7 but do not appear to interact with low density lipoprotein (LDL), 1 The purpose of the current study was to directly examine the role of intact apos in HDL receptormediated transport of excess cholesterol from cells. To remove intact apos from HDL3 under conditions that preserve the native lipid composition of the particles, apos were digested by mild treatment with proteolytic enzymes. We then tested these protease-modified particles for their abilities to bind to the 110-kd HDL binding protein and to promote efflux of cellular cholesterol from the plasma membrane and intracellular pools. Results indicate that whereas removal of cholesterol from plasma membranes is mediated by HDL lipids, HDL binding to the candidate receptor protein and selective removal of intracellular sterol require the presence of intact apos in HDL particles.
Methods

Cells and Cell Membranes
Cultured human skin fibroblasts and bovine aortic endothelial cells were grown and maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum as described previously. 1 
"
4 For cholesterol efflux experiments, fibroblasts were plated into 35-mm dishes at a density of 5 to 7 x 10 s cells/dish and grown to confluency (7-9 days). For preparation of cell membranes used in ligand-blotting studies, endothelial cells were plated and grown to confluency in 150-mm dishes.
Cell membranes were prepared according to Basu et al. 15 Briefly, washed endothelial cell monolayers were dislodged from dishes with a nylon policeman into 0.15 M NaCl, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride (PMSF) dissolved in dimethyl sulfoxide, and 10 mM Tris HC1, pH 7.4. Cells from four to five dishes were combined, pelleted by centrifugation at 200g for 5 minutes, resuspended in the same buffer, homogenized with two 5-second pulses of a polytron homogenizer (Tekmar model No. SDT 1810 with 10EN shaft, Cincinnati, Ohio), and then centrifuged at 800g for 10 minutes at 4°C. The supernatant was centrifuged at 100,000g for 60 minutes at 4°C, and the pellet was stored frozen for use in ligand-blotting studies.
Lipoproteins
Lipoproteins were isolated from human plasma by standard sequential ultracentrifugation techniques (LDL, d=1.019-1.063 g/ml; HDL3, d= 1.125-1.210 g/ml). Lipoproteins were iodinated by the modified McFarlane monochloride procedure (Bilheimer et al 16 ). Proteolytic digestion of HDL3 apos was performed by a modification of the method described by Hahm et al. 17 The proteolytic enzymes used for the digestions were trypsin (from porcine pancreas) (GIBCO, Grand Island, N.Y.) dissolved in 0.1 M Tris/0.01 M CaCl 2 , pH 8.0, and pronase (from Streptomycesgriseus) (Sigma Chemical Co., St. Louis, Mo.) dissolved in 0.1 M Tris HC1, pH 7.3. To start the reaction, 200 fil enzyme solution was added to 1.0 ml 0.15 M NaCl and 1 mM EDTA (pH 7.2) containing 10 mg HDL3 at an enzyme-to-lipoprotein ratio of 1:40 (wt/wt). The reaction was continued for either 30 minutes (pronase) or 60 minutes (trypsin) at 37°C and then stopped by addition of 20 pi 0.1 M PMSF in ethanol. The reaction mixture was cooled to 4°C, and protease-modified core particles were isolated from cleaved and dissociated peptides by chromatography on a Sephadex G-75 column (Pharmacia LKB Biotechnology, Inc., Piscataway, N.J.). The modified particles were dialyzed at 4°C against 0.15 M NaCl plus 1 mM EDTA, filtered (0.22-/xm pore size), and stored at 4°C. Control HDL3 ("native" HDL3) was subjected to the same protocol as trypsin-treated HDLj except that the enzyme was omitted from the reaction mixture. An aliquot was assayed for protein 18 and phospholipid 19 composition.
Electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed by the method of Laemmli 20 using a 12.5-17% gradient gel. Analysis of HDL3 particle size was performed by nondenaturing gradient gel electrophoresis as described previously. 12 Proteins were identified by Coomassie Blue staining.
Ligand Blotting
Membrane pellets were solubilized by needle aspiration into SDS-PAGE electrophoresis buffer (with /3-mercaptoethanol) and boiled for 3 minutes. Samples containing equal amounts of protein (500 ^.g) per lane were electrophoresed on 7% polyacrylamide slab gels, and separated proteins were transferred to nitrocellulose membranes (0.45 fim) by electrophoresis. 1 To assay binding activity, nitrocellulose membranes were first incubated for 2 hours at room temperature with blocking buffer (10 mM Tris HC1, pH 7.4, 150 mM NaCl, 10% [wt/vol] nonfat dried milk, 0.01% [vol/vol] antifoam A, 50 Mg/ml LDL) and then incubated for 2 hours at room temperature in the same buffer containing 5 yxg/ml 125 I-HDL, (4 JAM phospholipid) plus the indicated concentration of competitor. Nitrocellulose membranes were washed at room temperature once rapidly and then five times for 10 minutes with LDL-free blocking buffer. Protein bands were visualized by autoradiography.
Differential Radiolabeling of Cellular Cholesterol Pools
Fibroblasts were loaded with cholesterol by incubation for 48 hours with serum-free DMEM containing 2 mg/ml bovine serum albumin (BSA) plus 50 /xg/ml cholesterol added in ethanol (from a 10 mg/ml cholesterol stock). 22 However, subsequent studies revealed that the transfer rate was slow even at 37°C, provided that the cells were first loaded with cholesterol.
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Representative experiments using pulse incubations at both temperatures are included as indicated in the figure legends. For the 15°C pulse incubations, cholesterol-loaded fibroblasts were washed five times at room temperature with phosphate-buffered saline containing 1 mg/ml BSA (wash buffer) and chilled to 0°C during the last wash. Dishes then received ice-cold ./V-2-(hydroxyethyl)piperazine-./V'-(2-ethanesulfonic acid) (HEPES)-buffered DMEM containing 1 mg/ml BSA, 2 jig/ml acyl coenzyme A:cholesterol acyltransferase (ACAT) inhibitor 58.035 (Sandoz, East Hanover, N.J.), and 0.4 mM [ 3 H]mevalonolactone (10 j/.Ci/ml). Cells were incubated in a 15°C water bath for 6 hours, chilled on ice, washed five times with ice-cold buffer, and used in sterol efflux and translocation experiments. Cells were treated identically for the 37"C pulse incubation except that they were maintained at room temperature during the last wash, labeling media were prewarmed to 37°C, and cells were incubated in a 37°C water bath for 3 hours.
To 
Sterol Efflux From Cells
Washed monolayers of cholesterol-loaded and radiolabeled cells were incubated at 37°C with HEPESbuffered DMEM containing 1 mg/ml BSA, 2 u-g/ml compound 58.035, and the indicated amounts of native and protease-modified HDL,. After the times indicated, cells were chilled on ice, the efflux medium was collected, and cells were washed three times with cold wash buffer and twice with BSA-free wash buffer. Medium and cells were stored frozen until extraction for lipid and protein analyses, or cells were assayed immediately for plasma membrane-associated sterol as described below.
Sterol Translocation Between Cellular Pools
Translocation of newly synthesized [ 3 H]sterol between cellular pools was measured by a modification 1011 of the method described by Lange and Ramos. 22 After the efflux medium was collected and cells were washed, cells were fixed by exposure to 1% glutaraldehyde for 10 minutes at 0°C. The fixed cells were washed five times with cold phosphate-buffered saline and transferred to a 37°C water bath. Cells were then incubated at 37°C for 
Lipid Analysis
Washed cell monolayers were extracted with hexane/isopropanol (3:2, vol/vol) as previously described. 23 Lipids were extracted from efflux medium by the method of Folch et al. 24 Sterol species were separated on silica gel G thin-layer chromatography plates (PE sil G, Whatman, Clifton, N.J.), developed in heptane/diethyl ether/methanol/acetic acid (80:30:10:2, vol/vol/vol/vol) and were detected with I 2 . For isotope measurements, individual spots corresponding to cholesteryl esters, free cholesterol, and cholestenone were scraped into scintillation vials and counted. The biosynthetically labeled sterols that migrate with the cholesterol in this system represent 27-carbon sterol intermediates, which include zymosterol, desmosterol, and cholesterol but exclude lanosterol and its precursors. When fibroblasts were pulsed with [ 3 H]mevalonolactone, greater than 85% of the newly synthesized 27-carbon sterols were oxidized and comigrated with cholestenone after extraction from silica gel with isopropanol, treatment with cholesterol oxidase, and rechromatography. Thus, since cholesterol oxidase appeared to react with all 27-carbon sterols, it was necessary to treat them as a homogeneous pool when using the cholesterol oxidase assay to measure cellular distribution of labeled sterol. To determine sterol mass, free and esterified cholesterol spots were scraped, extracted, and assayed by the cholesterol oxidase procedure described previously. 23 
Cholesterol Esterification and Sterol Biosynthesis
To assess the relative activity of ACAT and the sterol biosynthetic pathway, cells were washed and incubated for 1 hour at 37°C with serum-free medium containing [ M C]oleate (20 fiM) bound to albumin (0.3 mg/ml). Cells were then chilled on ice, washed twice with cold buffer, and extracted in hexane/ isopropanol. Lipid subclasses were separated by thinlayer chromatography, and incorporation of M C radioactivity into esterified and unesterified cholesterol was measured as described previously. 23 Incorporation ofradiolabel into esterified sterol represents sterol esterification by ACAT. Incorporation of radiolabel into unesterified sterol represents biosynthe- 
Results
Characterization of Protease-Modified High Density Lipoprotein 3
To degrade intact HDL3 apos, lipoprotein particles were treated with the proteorytic enzymes trypsin or pronase as described in "Methods." These treatment protocols reduced the Lowry-reacting proteins in the HDLj particles by 40-50% (trypsin) and 50-70% (pronase). SDS-PAGE showed that both trypsin-modified HDL3 (TrHDlo) and pronase-modified HDL3 (PrHDLj) contained no detectable intact apo A-II but retained a small amount of intact apo A-I ( Figure 1 ). Pronase treatment consistently caused a more extensive degradation of apo A-I than did trypsin treatment. Most of the assayable protein that remained associated with the protease-modified particles was in the form of low-molecular-weight peptides. For the gel shown in Figure 1 , the same amount of total protein was added for each sample. Thus, the lanes with protease-modified HDL3 contained protein from two to three times more particles than did the lane for native HDL3. Based on densitometric scanning of this and other gels, it was estimated that protease treatment completely or partially digested greater than 80% of the HDL3 apos.
Modified and native particles had the same ratios of unesterified and esterified cholesterol to phospholipid, indicating that the relative composition of the major HDL3 lipid components was unchanged by treatment with either enzyme (data not shown), as also reported by others.
14 ' 2526 Nondenaturing gradient gel electrophoresis indicated that the size distribution of HDL, particles was unaffected by protease treatment. To normalize values for particle concentration and surface area, lipoproteins were quantified according to phospholipid content.
Recent studies from our laboratory have identified a 110-kd membrane protein that specifically binds HDL and phospholipid vesicles containing apo A-I and apo A-II. 1 To test the effects of proteolytic degradation of HDL3 apos on lipoprotein binding to this candidate receptor protein, we performed competitive binding studies using the ligand-blotting protocol described in "Methods." The choice of cell type for these studies was cultured bovine aortic endothelial cells, since membranes from these cells have a high abundance of HDL-binding protein. 1 The same protein appears to be present in cultured fibroblast membranes.
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When endothelial cell membrane proteins were separated by SDS-PAGE and transferred to nitrocellulose membranes, autoradiographs revealed a 110-kd protein that interacted with '"I-HDL, (Figure 2 ). The addition of excess unlabeled HDL, to the binding medium reduced the signal by more than 80%, indicating that 125 I-HDL, binding to this protein is saturable and can be reduced by competition with unlabeled ligand. However, addition of excess unlabeled TrHDIô r PrHDL, had little effect on 125 I-HDL3 binding to the 110-kd protein, indicating that protease-modified lipoproteins interact poorly with the HDL-binding protein.
Promotion of Cholesterol Efflux From Different Cellular Pools by High Density Lipoprotein 3 and Protease-Modified High Density Lipoprotein 3
Previous results from our laboratory have suggested that binding of HDL to its high-affinity bind- ing sites promotes removal of sterol from intracellular pools, whereas transport of cholesterol directly from plasma membranes to HDL occurs independently of HDL binding. 1011 Since cholesterol loading of cells increases the number of high-affinity sites, we compared the effects of protease treatment of HDL, on its ability to promote efflux of labeled sterol from cholesterol-depleted and cholesterol-loaded cells.
To prelabel intracellular pools of unesterified sterol without increasing sterol mass, cells were pulsed with the biosynthetic precursor [ sor because it bypasses hydroxymethylglutaryl coenzyme A reductase, the enzyme in the biosynthetic pathway that undergoes the largest degree of regulation in response to changes in cell cholesterol content.
Before the efflux studies, experiments were conducted to test the effects of cholesterol loading on biosynthetic labeling of sterol and its cellular distribution. To assess the relative distribution of sterol between cellular pools, cells were fixed with glutaraldehyde and treated with cholesterol oxidase (see "Methods"). When fibroblasts were preincubated with lipoprotein-deficient serum to deplete cells of cholesterol, most of the biosynthetically labeled sterol appeared in cholesterol oxidase-accessible pools (Figure 3 ), presumably because of rapid translocation to the plasma membrane.
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- 28 Addition of nonlipoprotein cholesterol to this medium led to a reduction in both sterol synthesis and the relative proportion of labeled sterol appearing in cholesterol oxidase-accessible pools. Removal of serum from either the cholesterol-free or cholesterol-enriched medium caused a further suppression of sterol synthesis and cholesterol oxidase accessibility, probably because serum growth factors were removed. Previous studies have suggested that inhibition of cell proliferation increases the pool size of the intracellular sterol that regulates biochemical processes. 9 The lowest rates of sterol synthesis and incorporation of newly synthesized sterol into cholesterol oxidaseaccessible pools occurred when cells were loaded with cholesterol in the absence of serum and in the presence of an ACAT inhibitor. Thus, as cells accumulate more unesterified cholesterol, there are progressive decreases in both the rates of sterol synthesis from mevalonolactone and relative cholesterol oxidase accessibility.
The decrease in cholesterol oxidase accessibility caused by cholesterol loading of cells could not be attributed to reduced biosynthesis of radiolabeled sterol. A time course revealed that the distribution of newly synthesized [ The above results suggest that cholesterol loading of cells traps newly synthesized radiolabeled sterol within intracellular pools of cholesterol that are inaccessible to cholesterol oxidase. These pools appear to be in rapid equilibrium with the substrate pool for the microsomal esterifying enzyme ACAT. When the ACAT inhibitor was omitted during the 3-hour pulse-labeling incubations, more than 73% of the newly synthesized sterol was esterified (Table 1) . In contrast, less than 10% of the newly synthesized sterol was esterified in cholesterol-depleted cells. The efficient conversion to esters in cholesterolloaded cells indicates that newly synthesized sterol tracer rapidly enters the ACAT substrate pool before exchange with the much larger cellular pool of unlabeled cholesterol. To eliminate the cholesteryl-ester cycle as a variable, an ACAT inhibitor was included in all pulse-chase incubations using the biosynthetic labeling protocol.
When sterol-loaded cells were pulsed with [ 3 H]mevalonolactone and chased with medium containing unlabeled mevalonolactone plus either native HDL3 or TrHDL^, the unmodified particles were much more effective than modified HDL3 in promoting efflux of labeled sterol ( Figure 5A ). In contrast, when cells were depleted of cholesterol before the pulsechase incubations ( Figure 5B), TrHDL, had a slightly greater ability than native HDL, to promote sterol efflux. Moreover, HDL3 removed a larger percentage of newly synthesized sterol from cholesterol-loaded cells than from cholesterol-depleted cells ( Figure 5 ), even though the loaded cells incorporated most of the labeled sterol into cholesterol oxidase-inaccessi- 
H]mevalonolactone as described in Figure 3 legend. After the indicated time (hours, h), cells were fixed and treated with cholesterol oxidase (CO) in hypotonic buffer for 30 minutes, and incorporation of label in CO-accessible (o) and CO-inaccessible (•) sterol was measured as described in "Methods." Results are mean of three incubations expressed as either radioactivity counts ( 3 H-sterol, cpm/dish; panel A) or percent of total 3 H-sterol (panel B). Standard error bars are included in panel A unless within the dimension of the symbols. ACAT, acyl coenzyme A: cholesterol acyltransferase.
ble pools. Thus, it appears that HDL apos facilitate efflux of biosynthetically labeled sterol only when cells are loaded with cholesterol, and most of the labeled sterol initially resides in intracellular pools that are inaccessible to cholesterol oxidase. In contrast, HDL apos do not appear to play a role in promoting sterol efflux from cholesterol-depleted cells when most of the label resides within the plasma membrane.
These studies raise the possibility that HDL apos selectively mediate removal of intracellular sterol from cholesterol-loaded cells. To further test this possibility, [ Figure 3 legend except that acyl coenzyme A: cholesterol acyltransferase inhibitor was omitted during the labeling incubation. Cell lipids were extracted and radiolabeled, and unesterified and esterified cholesterol was measured as described in "Methods." Each value represents mean±SEM of 12 incubations. Values in parentheses represent percent total counts. label plasma membranes. Again, native HDL3 was more effective than either TrHDL^ or PrHDL^ in promoting labeled sterol efflux derived from a biosynthetic precursor ( Figure 6A ). However, similar to what was observed for efflux of biosyntheticalry labeled sterol from cholesterol-depleted cells ( Figure 6B ). These results provide additional evidence that HDL apos mediate removal of sterol from intracellular pools of cholesterol-loaded cells but not from the plasma membrane.
FIGURE 6. Line plots showing removal of [ 3 H]sterol from intraccllular pools and plasma membranes of cholesterolloaded cells by native and protease-modified high density lipoprotein 3 (HDL 3 ). As described in "Methods
Addition of native HDL3 to the chase medium increased efflux of biosyntheticalry labeled sterol from cholesterol-loaded fibroblasts during the first 2 hours of incubation, after which efflux subsided (Figure 7 ). This early rapid-efflux phase was not evident when cells were exposed to an equal concentration of TrHDLj.
Lipoprotein-Mediated Translocation of Cholesterol Between Cellular Pools
Our previous studies 10 - 11 suggested that HDL3 selectively removes intracellular sterol by stimulating translocation of sterol from intracellular pools to the cell surface where it becomes accessible to HDL3 particles. To assess the role of HDL apos in this translocation process, we measured the effects of native or TrHDL, on the distribution of endogenously synthesized [ Figure 8B ). These results are consistent with our previous studies 1011 showing that HDL3 stimulates translocation of sterol from intracellular sites that are inaccessible to cholesterol oxidase to sites that are accessible to this enzyme. This stimulatory process appears to be mediated by HDL apos.
Effects of Native and Trypsin-Modified High Density Lipoprotein on Depletion of Sterol Mass Within Intracellular Pools
To test whether the HDL^-stimulated depletion of biosynthetically labeled sterol within cholesterol oxidase-inaccessible pools represents net mass movement of intracellular sterol, we measured the effects of native and TrHDLj on the activities of two biochemical processes known to be regulated reciprocally by changes in the size of microsomal pools of sterol: cholesterol esterification (ACAT activity) and sterol biosynthesis. The relative activities of these two processes were assayed by pulse incubating cells for 1 hour with [ medium, the relative activities of ACAT and the sterol biosynthetic pathway remained constant for up to 8 hours (Figures 9A and 9B) . Addition of HDL3 to the medium led to a decrease in ACAT activity ( Figure 9A ) in association with an increase in the rate of sterol synthesis ( Figure 9B ), indicating that HDL3 depleted cells of intracellular sterol pools that regulate these two processes. In contrast, TrHDL, had no effect on either ACAT activity or the rate of sterol biosynthesis.
To monitor efflux of plasma membrane-derived cholesterol in the same experiment, plasma membranes were radiolabeled by including [ H]cholesterol was increased by addition to the medium of both forms of HDL, particles ( Figure 9C ). These results further indicate that depletion of intracellular regulatory sterol pools but not other pools of cholesterol is mediated by HDL apos.
HDL apos also mediate depletion of intracellular sterol pools derived from the uptake and degradation of LDL particles. When HDL3 was added to medium containing LDL during 24-hour incubations, there was a dose-dependent decrease in the ACAT activity ( Figure 10A ) in parallel with a decrease in the cellular cholesteryl ester content ( Figure 10B ). These data are consistent with previous results 29 showing that HDL3 removes intracellular sterol at a rate that exceeds delivery of LDL sterol, even though receptor-mediated uptake of LDL is enhanced by addition of HDL, (apparently in response to depletion of the intracellular sterol regulatory pool). In contrast to native HDL,, addition of TrHDL, or PrHDL, to the LDL medium had little effect on either ACAT activity or cellular cholesteryl ester mass. The much larger pool of unesterified cholesterol, most of which presumably resides in plasma membranes, 22 decreased only slightly in the presence of increasing concentrations of either unmodified or modified HDL3 ( Figure IOC) . These results are consistent with the conclusion that HDL3 apos, rather than lipids, mediate the selective removal of intracellular pools of cholesterol.
Discussion
The current study demonstrates that digestion of HDL3 apos with proteolytic enzymes reduces the ability of HDL3 to remove sterol from cholesterolloaded fibroblasts. Exposure of cholesterol-loaded cells to HDL3 suppressed ACAT activity, decreased cholesteryl ester mass, and stimulated efflux of labeled sterol derived from intracellular pools. All these effects were markedly reduced by treatment of HDL3 with trypsin or pronase. In contrast, protease treatment did not reduce the ability of HDL3 to promote efflux of labeled sterol associated with the plasma membrane. These results indicate that HDL, apos mediate selective removal of excess cholesterol from intracellular pools of sterol-laden cells.
For some of the selective-removal assays used in this study, unesterified cholesterol pools were radiolabeled by incubating cells with the biosynthetic precursor [ 32 However, most of these labeled 27-carbon sterols rapidly equilibrate with intracellular pools of cholesterol. This conclusion was based on results showing that when cholesterol-loaded cells were incubated with [ 3 H]mevalonolactone in the absence of an ACAT inhibitor, more than 70% of the newly synthesized sterol was esterified. Thus, this biosynthetic labeling procedure provides an efficient means of introducing sterol tracer into the substrate pool for ACAT.
The biosynthetically labeled 27-carbon sterols also appear to behave as a homogeneous pool with respect to sterol trafficking. Twenty-seven-carbon sterols excreted from cells in the presence of HDL3 have a subspecies composition similar to that retained by cells, 11 indicating that the different subspecies are transported within and from cells at similar rates. These findings are consistent with a recent study by Echevarria et al 32 showing that endogenously synthesized zymosterol and cholesterol are transported from cells with the same kinetics. Therefore, it was assumed that labeling sterol pools with a biosynthetic precursor in the presence of an ACAT inhibitor was a valid procedure for studying efflux of cholesterol derived from intracellular pools.
Treatment of cells with cholesterol oxidase was used to monitor movement of labeled sterol between cellular pools. Many studies 32 have demonstrated that newly synthesized sterol first enters a cholesterol oxidase-inaccessible pool before transport to the plasma membrane. The current study extends our previous reports 1011 by showing that loading cells with cholesterol and inhibiting cell proliferation suppress the rate at which newly synthesized sterol tracer is translocated from oxidaseinaccessible to oxidase-accessible pools. The most straightforward explanation for these results is that as cells accumulate cholesterol or require less for new membrane synthesis, the newly synthesized sterol becomes trapped within intracellular pools of cholesterol, which are translocated very slowly to the plasma membrane.
Exposure of cholesterol-loaded cells to native HDL, but not to TrHDL, decreased the amount of labeled sterol within cholesterol oxidase-inaccessible pools and increased the amount within oxidaseaccessible pools. These data suggest that the interaction of HDL3 apos with cholesterol-loaded cells stimulates translocation of sterol from one intracellular pool to other cellular pools that are accessible to cholesterol oxidase. It cannot be concluded that the intracellular sterol is translocated exclusively to the plasma membrane, since recent studies have shown that cholesterol oxidase treatment may damage cell membranes and expose some intracellular pools to the enzyme.
3S Although the precise cellular locations of the cholesterol oxidase-accessible pools are unknown, they are likely to represent intermediates in the excretory pathway, since the HDL-stimulated translocation of labeled sterol from cholesterol oxidase-inaccessible to -accessible pools was associated with a parallel increase in cholesterol efflux.
Stimulation of radiolabeled sterol translocation and efflux by HDL, reflects net mass transport of cholesterol. Exposure of cells to HDL3 suppressed ACAT activity and reduced the cellular cholesteryl ester content, implying that HDL3 depleted the intracellular cholesterol mass that was a substrate for ACAT. Protease treatment of HDL, almost completely abolished the ability of HDL, to deplete this intracellular pool, indicating that this process is mediated by HDL apos. Taken together, these different assays provide evidence that HDL3 apos activate one or more steps that translocate unesterified cholesterol from ACAT-accessible intracellular pools into an excretory pathway.
It is unlikely that the stimulatory effect of HDL3 on sterol translocation is secondary to removal of cholesterol from the plasma membrane. HDL3 treated with either TNM 10 -11 or proteases (this study) has the same or greater ability than untreated HDL3 to promote efflux of plasma membrane sterol, and yet the modified particles do not stimulate sterol translocation. Incubation of LDL-treated cells with native or modified HDL3 caused similar small decreases in unesterified cholesterol mass, most of which presumably resides in the plasma membrane, 22 -27 indicating that both types of particles promoted net transport of cholesterol from the plasma membrane. Thus, our data demonstrate that flux of sterol between the plasma membrane and HDL particles is not mediated by the interaction of HDL apos with cells, in agreement with results reported by others. 36 -38 The protease treatment protocols used in the current study do not provide information about the nature of the apos involved in stimulating intracellular sterol translocation. When HDL3 was treated with either trypsin or pronase, most of the apos were degraded to peptide fragments. Studies using isolated HDL apos are currently being conducted in our laboratory. Preliminary results indicate that lipidfree apo A-I can stimulate translocation of intracellular sterol to the plasma membrane under conditions where sterol efflux does not occur, 39 suggesting that apo A-I alone can modulate the sterol translocation pathway. It is not yet known if other HDL apos have any direct effect on sterol trafficking in cells.
Although there are several possible explanations for the stimulatory effect of HDL apos on translocation and efflux of intracellular sterol, one possibility is that HDL conveys a signal to cells to initiate translocation of excess intracellular sterol to the plasma membrane, a process that may be mediated by receptor binding of HDL apos. We have identified a 110-kd membrane protein that has many features predicted for an HDL receptor, including specificity for HDL apos and regulation by changes in cell cholesterol content.
1 - 9 The current study shows that binding of HDL to this candidate receptor protein is reduced by protease treatment of the lipoprotein particles. The HDL receptor hypothesis is consistent with earlier studies 2^12 showing that some but not all of the cholesterol efflux from sterol-loaded cells correlates with binding of HDL, to high-affinity sites on the cell surface. It is now apparent that sterol effux from cells has at least two components: sterol translocation and efflux from intracellular pools, and transport of plasma membrane sterol to extracellular acceptor particles. It is only the first component that is mediated by HDL apos, possibly through their interaction with cell-surface receptors.
